Summary:
Five patients with confirmed congenital amegakaryocytic thrombocytopenia (CAT) underwent stem cell transplantation (SCT) from HLA-matched related donors at King Faisal Specialist Hospital and Research Center (KFSHRC). The median age at SCT was 3.2 years (range, 0.4–5 years). Conditioning regimen consisted of busulfan (BU) 4 mg/kg p.o. for 4 days (total dose of 16 mg/kg), and cyclophosphamide (CY) 50 mg/kg once daily i.v. for 4 days (total dose of 200 mg/kg). Antithymocyte globulin (ATG) was given i.v. at a dose of 30 mg/kg for 4 days pre-SCT (total of 120 mg/kg); graft-versus-host disease (GVHD) prophylaxis was with cyclosporine and methotrexate. Four patients engrafted and are alive and transfusion independent with a median follow up time of 30 months (range, 16–45 months). One patient failed to engraft and underwent a second SCT 4 months later but died of respiratory failure. We conclude that the use of allogeneic SCT may be curative for such patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alter BP, Young NS . Amegakaryocytic thrombocytopenia. In: Nathan DG, Oski FA (eds) Hematology of Infancy and Childhood. Saunders: London, 1998, pp 281–282.
Brochstein JA, Shank B, Kernan NA et al. Marrow transplantation for thrombocytopenia – absent radii syndrome. J Pediatr 1992; 121: 587–589.
Lackner A, Basu O, Bierings M et al. Hematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. Br J Haematol 2000; 109: 773–775.
MacMillan ML, Davies SM, Wagner JE, Ramsay NKC . Engraftment of unrelated donor stem cells in children with familial amegakaryocytic thrombocytopenia. Bone Marrow Transplant 1998; 21: 735–737.
Kudo K, Kato K, Matsuyama T . Successful engraftment of unrelated donor stem cells in two children with congenital amegakaryocytic thrombocytopenia. J Pediatr Hematol Oncol 2002; 24: 79–80, (letter).
Yesilipek, Hazar V, Kupesiz A, Yegin O . Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia. Bone Marrow Transplant 2000; 26: 571–572.
Ballmaier M, Germeshausen M, Schulze H et al. C-Mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood 2001; 97: 139–146.
Mukai HY, Kojima H, Todokoro K et al. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thromb Haemost 1996; 76: 675–678.
Cremer M, Schulze H, Linthorst G et al. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias. Ann Hematol 1999; 78: 401–407.
Kaushansky K . Thrombopoietin: the primary regulator of platelet production. Blood 1995; 86: 419–431.
Van Den Oudenrijn S, Bruin M, Folman CC et al. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol 2000; 110: 441–448.
Gillio AP, Gabrilove JL . Cytokine treatment of inherited bone marrow failure syndromes. Blood 1993; 81: 1669–1674.
Guinan EC, Lee YS, Lopez KD et al. Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia. Blood 1993; 81: 1691–1698.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al-Ahmari, A., Ayas, M., Al-Jefri, A. et al. Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT). Bone Marrow Transplant 33, 829–831 (2004). https://doi.org/10.1038/sj.bmt.1704445
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704445
Keywords
This article is cited by
-
Strategien zur Behandlung von Thrombozytopenien im Kindesalter
Monatsschrift Kinderheilkunde (2006)